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Abstract 
Neurotransmitters mediate synaptic communication 
between neurons and are therefore fundamental to such 
essential human characteristics as learning, memory, 
cognition and persona. Recent work indicates that 
neurotransmitters and their receptors are also used for 
communication between non-synaptic elements of the 
nervous system and may be involved in glial-glial, glia-
axon and glial-neuronal information transfer and 
processing. We have recently found evidence that glial 
cells in developing white matter, which contains no 
synapses or neuronal somata, express a wide variety of 
neurotransmitter receptors, including the NMDA-type 
glutamate receptor that had long thought to be exclusively 
neuronal. At the point when white matter is laying down 
myelin and glial cells are forming their long-term 
morphological arrangement with axons, NMDA receptors 
mediate post-synaptic-potential input onto glia and may be 
crucially involved in stabilizing glial-axonal cyto-
architecture. There is also strong evidence that glutamate 
receptors on glial cell membranes greatly heighten the 
cells susceptibility to injury, a phenomenon that may 
explain the selective damage of developing white matter 
found in common human birth disorders such as cerebral 
palsy. There are many potential sources of extracellular 
glutamate in ischemic white matter including axons, 
oligodendrocytes, reverse glutamate transport, loss of 
astrocyte processes and astrocyte swelling. These potential 
pathways for glutamate release are described here. 
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Introduction 
Cerebral palsy (CP) is the most common human 
birth disorder, having a prevalence of 2-3:1000 live 
births in the West (and much higher in the 3rd world).1 
CP is manifest in the first years of life and continues 
unabated throughout the lifetime of the patient; there 
are currently no effective remedies or prophylactic 
strategies.2 In the majority of cases, CP involves an 
apparently ischemic lesion "periventricular 
leukomalacia" (PVL) located within developing white 
matter (WM) structures such as those adjacent to the 
ventricles,2,3 or "periventricular white matter injury" 
(PWMI) which is centered upon these structures but 
has a more diffuse distribution.4 Patients suffer a 
variety of symptoms including  motor, sensory and 
cognitive deficits.2,4 CP is an incurable lifelong 
disorder of high prevalence and deserves high priority 
within medical research. The development of an 
effective intervention to protect developing WM is an 
important goal and is dependent upon an 
understanding of the basic cellular mechanisms 
involved in the early stages of the injury. Interventions 
might be effective both in the fetus at risk identified by 
recent developments in fetal screening or in very 
premature infants who may suffer WM injury post-
partum.5-7 This paper will examine the mechanisms 
underlying the central pathophysiological event in 
ischemic injury of developing WM: glutamate release.  
 
PVL is characterized by damage to axons and death 
of glia, features that may be apparent within 4 hours of 
the onset of injury.8 Severe cases exhibit focal injury 
described as “coagulating necrosis” while diffuse 
cases of PWMI feature widespread loss of 
oligodendrocytes (OLs) and marked delayed 
hypomyelination.9 The location of the damage in 
periventricular WM is related in part to a low security 
of blood flow in this region at this age,2 and in part to 
an extremely high vulnerability to ischemia in 
developing WM OLs.10,11 The majority of cases arise 
during mid-term,10 and coincide with a key point in 
OL development. At this age, OL precursor cells are 
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progressing to the immature OL stage.12 In cell culture, 
immature OLs are more sensitive to ischemic injury than 
any other CNS cell type examined,13 and in situ they are at 
least twice as sensitive to acute ischemia as astrocytes or 
axons.13-15 OLs are the myelinating elements of the CNS, 
and are essential for saltatory conduction of action 
potentials. The high vulnerability to ischemia of the 
somata of immature OLs is partly a consequence of non-
NMDA glutamate receptor (GluR) expression,16-19 while 
the processes of these cells express NMDA GluRs which 
make them even more susceptible to ischemic-type injury. 
The physiological significance of GluR expression on OLs 
is not well understood. However, ischemia evokes a rapid 
elevation in extracellular glutamate in the developing 
nervous system, including developing WM,20-23 gating 
GluRs and producing a toxic influx of Ca2+.11,13-15  
  
The build-up of extracellular glutamate responsible for 
OL GluR activation is central to the injury process and 
may originate from a variety of sources (Figure 1). Axons 
are one potential source of extracellular glutamate (Figure 
1, "1"),2,11 and mature spinal cord axons contain glutamate 
that may be lost under ischemic conditions.24 OLs also 
contain glutamate in situ,24 and in vitro studies suggest that 
immature OLs release glutamate during OGD (Figure 1, 
"2").13 However, immature OLs in situ show robust 
accumulation of glutamate during OGD rather than the 
depletion that would accompany glutamate release.14,15 
Differences in excitatory amino acid transport (EAAT) 
expression in OLs in situ and in vitro may explain this 
paradox.25 Astrocytes are an important source of glutamate 
release during ischemia in the mature CNS, with release 
mediated by several potential mechanisms.26,27 Glutamate 
release from mature gray matter astrocytes is partly 
mediated by excitatory amino acid transporters (EAATs), 
which are also expressed in developing WM astrocytes 
(Figure 1, "3").25 In addition to potential transport-
mediated release, astrocytes in developing WM are subject 
to loss of cell processes (clasmatodendrosis), which will 
liberate intracellular glutamate into the extracellular space 
(Figure 1, "4"). The mechanism of acute astrocyte injury 
involves Na-K-Cl-cotransport (NKCC) and cell 
swelling,14,15 and swelling-mediated astrocyte glutamate 
release represents a further potential source of extracellular 
glutamate (Figure 1, "5").28,29 Additionally, glutamate 
release from hemi-channels,30,31 cystine-glutamate 
exchange32 and P2X7 receptor33 has to be considered. 
There are therefore a number of potential pools of 
glutamate available for release in ischemic developing 
WM, and a variety of possible mechanisms to mediate 
escape from these pools.  
 
Figure 1. Potential sources of glutamate release in 
developing white matter (see text for details). 
 
Following the onset of ischemia modeled as 
oxygen-glucose withdrawal (OGD), aliquots collected 
from isolated perfused post-natal day 10 rat optic 
nerve (RON) reveal delayed rises in aspartate and 
glutamate from a stable baseline (Figure 2, top panel). 
The non-transmitter amino acids serine and threonine 
(Figure 2, bottom) were also assayed and their delayed 
release may correlate with the cell membrane 
breakdown that is ongoing in the P10 RON after 30-40 
min.13-15,34 The extra-cellular space of the isolated 
RON is in communication with the bathing medium 
and measuring glutamate levels in the perfusate during 
control perfusion and during OGD shows net 
glutamate release from all the elements within this 
model WM structure. A similar approach has recently 
been used in mature mouse optic nerve.30  
 
Figure 2. Release of amino acids from P10 rat optic nerve. 
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EAATs are responsible for clearing synaptically 
released glutamate from the extracellular space of the 
CNS.26,35,36 Of the five EAATs that have been cloned, 
three are widely distributed in the mature CNS.35-38 
GLAST and GLT-1 are generally expressed at high levels 
and are located largely in glial cells, while EAAC1 is 
expressed at lower levels and is predominantly neuronal. 
The voltage and Na+-dependence of these glutamate 
transporters can result in the reversal of transport under 
ischemic conditions.26,39 EAAC1, GLAST and GLT-1 are 
expressed in mature WM,38,40-42 although the cellular 
distribution of these transporters is controversial.41,42 Little 
is currently known about the cellular distribution of these 
transporters in neonatal WM. Recent studies have shown 
that interruption of glutamate transport in WM leads to 
excitotoxic injury of axons and glia,43 highlighting the 
importance of glutamate clearance in WM structures. We 
have use transgenic mice where GFP expression is under 
the control of glial cell type specific promoters, coupled to 
standard immuno-histochemistry (IHC) to examine EAAT 
expression in the neonatal WM.44 This approach removes 
concerns about antibodies cross-reacting during double 
labeling and results show GLT-1 expression segregated to 
astrocytes in P10 optic nerve in GFAP-GFP animals with 
EAAC1 expression absent in these cells. Little GLAST 
expression was seen in the astrocytes. The IHC studies 
were coupled to staining for the uptake of exogenously 
perfused D-aspartate (D-Asp), which confirmed that the 
transporter expression detected by IHC is functional. D-
Asp is a non-metabolizable glutamate analogue taken-up 
and released from glia via the same mechanisms as 
glutamate, it is by far the best characterized glutamate 
analogue for this purpose.28,45  
  
In addition to reverse uptake, astrocyte swelling is also 
associated with glutamate release.46 Two pathways for 
swelling-induced glutamate release have been identified in 
cultured astrocytes. Swelling induced by high [K+]o can 
evoke a transient early phase of release that is mediated by 
EAATs.28,46 A more prominent delayed (~5 min) phase of 
release is sensitive to block by anion channel inhibitors 
such as L-644711 and NPPB, and is probably mediated by 
glutamate-permeable volume-sensitive anion channels 
(VSAC).26,28,47,48 In cultured astrocytes, delayed glutamate 
release can also be partially prevented by inhibition of 
NKCC with bumetanide or by NKCC oblation, while 
NKCC activation is required for high [K+]o induced 
astrocyte swelling.47,48 Swelling induced by hypotonic 
media produces glutamate release that is insensitive to 
bumetanide, but sensitive to L-6644711 and other anion 
channel blockers.49 Cell swelling is therefore associated 
with delayed glutamate release in an anion channels 
blocker sensitive fashion, while NKCC activation 
produces astrocyte swelling and recruitment of this 
mechanism. A role for VSAC-mediated glutamate 
release is indicated by some in vivo ischemia studies of 
gray matter.50 Other studies have shown VSAC 
activation block when intracellular ATP levels fall,51 
but it appears that astrocyte retain elevated 
cytoplasmic ATP for some time following the onset of 
ischemic conditions52. 
  
Confocal imaging was used to collect 3-D image 
stacks off individual cells in the optic nerve and corpus 
callosum slice from P10 GFP-GFAP mice. The image 
stacks were rendered and volume changes assessed. 
Figure 3 shows flattened image-stacks of a single 
GFP-astrocyte in a brain slice collected in this fashion, 
and underneath is a plot of the soma volume change 
(cell swelling) of this astrocyte during and after 30 min 
of OGD. Significant soma swelling is apparent during 
OGD which subsequently recovers. This preliminary 
data suggest that astrocyte swelling may be a 
significant source of glutamate release in developing 
white matter during ischemia. 
 
 
Figure 3. Astrocyte volume changes during OGD in P10 
mouse optic nerve (see text for details). 
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We have shown that developing WM astrocytes die 
rapidly during OGD,14,15 and that loss of astrocyte 
processes (clasmatodendrosis) is an early feature of 
developing white matter ischemia.53 Loss of astrocyte 
processes under ischemic conditions is rapid, being evident 
in model systems within 15 min.53,54 The detached 
processes rapidly lose membrane integrity, meaning that 
the relatively high concentration of glutamate in these 
structures will escape to the ECS.14,15 The importance of 
clasmatodendrosis in WM injury has not been established, 
but it seems likely that the rapid disintegration of 
glutamate-rich processed in the neighborhood of 
oligodendroglia has some role in the subsequent injury of 
those cells. The rapid shedding of processes following 
exposure to ischemic conditions does not involve the 
immediate lysis of the processes, which may maintain 
membrane integrity for several minutes. It appears 
therefore that clasmatodendrosis occurs in parallel with 
acute swelling of the somata, but is more rapid and 
proceeds via a different mechanism.  
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